Mostrar el registro sencillo

Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: an international study of ERIC, the European Research Initiative on CLL

dc.contributor.authorChatzikonstantinou, Thomas
dc.contributor.authorScarfò, Lydia
dc.contributor.authorMinga, Eva
dc.contributor.authorKarakatsoulis, Georgios
dc.contributor.authorChamou, Dimitra
dc.contributor.authorKotaskova, Jana
dc.contributor.authorIacoboni, Gloria
dc.contributor.authorDemosthenous, Christos
dc.contributor.authorAlbi, Elisa
dc.contributor.authorAlcoceba, Miguel
dc.contributor.authorAl-Shemari, Salem
dc.contributor.authorAurran-Schleinitz, Thérèse
dc.contributor.authorBacchiarri, Francesca
dc.contributor.authorChatzileontiadou, Sofia
dc.contributor.authorCollado, Rosa
dc.contributor.authorDavis, Zadie
dc.contributor.authorDeus Santos, Marcos Daniel de
dc.contributor.authorDreta, Barbara
dc.contributor.authorYáñez San Segundo, Lucrecia 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2024-12-16T18:27:58Z
dc.date.available2024-12-16T18:27:58Z
dc.date.issued2024
dc.identifier.issn2572-9241
dc.identifier.urihttps://hdl.handle.net/10902/34708
dc.description.sponsorshipFUNDING: This project was supported in part by AbbVie; AIRC under 5 per Mille 2018-ID. 21198 program (to PG and GG); PNRR-MAD-2022-12375673 (Next Generation EU, M6/C2_CALL 2022), Italian Ministry of Health, Rome, Italy, Conceptual development of research organization (FNBr 65269705) provided by the Ministry of Health of the Czech Republic, and National Institute for Cancer Research (Programme EXCELLES, ID Project No. LX22NPO5102) funded by the European Union—Next Generation EU.es_ES
dc.format.extent7 p.es_ES
dc.language.isoenges_ES
dc.publisherWolters Kluwer Healthes_ES
dc.rights© 2024 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceHemaSphere, 2024, 8(9), e70004es_ES
dc.titleTherapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: an international study of ERIC, the European Research Initiative on CLLes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1002/hem3.70004es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1002/hem3.70004
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail
Nombre:
TherapeuticStrategiesTreatment.pdf
Tamaño:
894.6Kb
Formato:
PDF
Descripción:
TherapeuticStrategiesTreatment

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2024 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2024 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.